ARMP AMEX
Armata Pharmaceuticals, Inc.
1W: +0.4%
1M: -40.8%
3M: -5.7%
YTD: +25.5%
1Y: +265.8%
3Y: +492.1%
5Y: +106.3%
$8.36
+0.13 (+1.58%)
Weekly Expected Move ±18.3%
$5
$7
$8
$10
$11
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$306.9M
52W Range1.74-16.34
Volume39,552
Avg Volume60,179
Beta1.32
Dividend—
Analyst Ratings
Company Info
CEODeborah L. Birx
Employees60
SectorHealthcare
IndustryBiotechnology
IPO Date1994-05-20
Websitearmatapharma.com
4503 Glencoe Avenue
Marina del Rey, CA 90292
US
Marina del Rey, CA 90292
US
858 829 0829
About Armata Pharmaceuticals, Inc.
Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has a partnership agreement with Merck & Co. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is headquartered in Marina del Rey, California.
Latest News
Armata Pharmaceuticals Announces Appointment of Biopharmaceutical Commercial Executive Daniel B. Gilmer, Ph.D. to its Board of Directors
12 Health Care Stocks Moving In Friday's After-Market Session
12 Health Care Stocks Moving In Tuesday's Intraday Session
Zenas Biopharma, Daqo New Energy And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Armata Pharmaceuticals GAAP EPS of -$3.42, revenue of $1.1M
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Gilmer Daniel B. | A-Award | 51,280 | $12.92 | 2026-04-24 |
| Gilmer Daniel B. | 0 | — | 2026-04-24 | |
| Kyme Pierre | F-InKind | 1,030 | $10.54 | 2026-03-14 |
| Birx Deborah | F-InKind | 4,919 | $10.54 | 2026-03-14 |
| Kramer Robin | A-Award | 25,640 | $11.61 | 2026-03-09 |